MedPath
HSA Approval

EPHEDRINE AGUETTANT SOLUTION FOR INJECTION 30MG/ML

SIN15912P

EPHEDRINE AGUETTANT SOLUTION FOR INJECTION 30MG/ML

EPHEDRINE AGUETTANT SOLUTION FOR INJECTION 30MG/ML

March 17, 2020

AGUETTANT ASIA PACIFIC PTE. LTD.

AGUETTANT ASIA PACIFIC PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAGUETTANT ASIA PACIFIC PTE. LTD.
Licence HolderAGUETTANT ASIA PACIFIC PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS

Medical Information

C01CA26

ephedrine

Manufacturer Information

AGUETTANT ASIA PACIFIC PTE. LTD.

Laboratoire AGUETTANT

Active Ingredients

EPHEDRINE HYDROCHLORIDE

30mg/ml

Ephedrine

Documents

Package Inserts

Ephedrine Aguettant Solution for Injection PI.pdf

Approved: June 21, 2022

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EPHEDRINE AGUETTANT SOLUTION FOR INJECTION 30MG/ML - HSA Approval | MedPath